PATENT CLAIM ANALYSIS

Application Number: 15906681
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "133100"]

Abstract:
The present disclosure provides compositions and methods useful for treating or preventing diseases or disorders where beta amyloid accumulation or aggregation contributes to the pathology or symptomology of the disease, for example Alzheimer's disease.

Claim (Index 16):
The method of  claim 13 , wherein the agent is an anti-CD33 antibody or an antigen binding fragment thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.19355
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14780242', '13701758', '12918739', '15034370', '11185907']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7034485730735018
- 35 USC 102 Novelty (BERT): 0.6193361245397633
- Combined Prediction Score: 0.695037328220128
- Mean Citation Score: 372.05095200000005
- Max Citation Score: 635.8073
- Similarity Product: 467.0051932231784

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test